Syncytiotrophoblast-derived Extracellular Vesicles in Placenta Previa and Accreta Spectrum
Recruiting
N/A
Interventional Study
Placenta Previa
Placenta Accreta Spectrum
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Healthy Volunteers Welcome
You do not need to have the condition being studied to take part.
At a Glance
- Age
- 18 and older
- Sex
- Female
- Study type
- Interventional
- Purpose
- Basic Science
- Participants needed
- 70 (estimated)
- Sponsor
- Fondazione Policlinico Universitario Agostino Gemelli IRCCS · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The main goal of this case-control study is to quantify the levels of circulating syncytiotrophoblast-derived extracellular vesicles (STBEVs) in maternal blood in a population of women with placenta previa and placenta accreta spectrum.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Pregnant women with diagnosis of placenta previa and accreta spectrum (cases)
* Healthy pregnant women
* \> 18 years
Exclusion Criteria:
* \< 18 years
* Twin pregnancies
* Chronic Infections
* Cancers
* Unable to give the written consent
Contacts